Treatment of Great Saphenous Vein Varicosities | Clinical Trial | StuddyBuddy@endsection Treatment of Great Saphenous Vein Varicosities
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05655416

Treatment of Great Saphenous Vein Varicosities

Conditions: Varicose Veins

Ages: 20 Years – 60 Years
Phase: NA
Enrollment: 55
Sponsor: Al-Azhar University

Location: Egypt

Summary

Venous insufficiency at lower extremities may result in clinical problems from cosmetic issues to ulcerations. When the frequency of venous insufficiency and its related problems are considered besides their diversity, it is encountered as a public health issue. This pathology is reported to affect 40% of women and 20% of men.1 Patients with varicose veins may complain of unsightly appearance, aching, heaviness, pruritus, and early fatigue of the affected leg. These symptoms worsen with prolonged standing and sitting and are relieved by elevation of the leg above the level of the heart. Also, mild edema is often present. More severe signs include thrombophlebitis, hyperpigmentation, lipodermatosclerosis, ulceration, and bleeding

Eligibility Criteria

Inclusion Criteria:Patients presented by primary VV of the LL complaining of Leg pain cosmetic disfigurement, leg ulcer, itching, or pigmentation at LLthe incompetence of the saphenofemoral junction (SFJ) and or saphenopopliteal junction (SPJ).Exclusion Criteria:Lower limb involvement by any of the following conditions; secondary VV, recurrent VV, lymphedema, acute superficial thrombophlebitis, arterio-venous fistula (congenital or acquired), congenital anomalies of the venous system, general comorbidities, skin infection or ischemia

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05655416). StuddyBuddy aggregates publicly available trial information.